Bluebird Bio's sickle cell gene therapy working for French boy 13.06.2015 12:35 Reuters LONDON (Reuters) - A pioneering gene therapy for sickle cell disease is working well so far for a 13-year-old French boy with the hereditary blood disorder, researchers said on Saturday, in a boost for the technology to fix faulty genes.
